Issue link: https://www.e-digitaleditions.com/i/1509086
"With 80 years of combined experience working with Captisol and other cyclodextrins, our team is ready for any formulation challenge and look forward to helping you bring your product to market." — Lian Rajewski, PhD, Sr. Research Investigator The scientists at Ligand Pharmaceuticals are experts at working with Captisol, have developed products in-house and aided clients in developing many successful formulations. Our expertise in navigating CMC, regulatory, and clinical issues is unparalleled in the industry. Captisol is a solubility enhancing excipient (derivatized cyclodextrin) that has been on the market for over 20 years and is in more than a dozen approved products. Your Partner in Solubility. Our Team is Ready. Are you? Contact us today! 858.550.5632 | cdinfo@captisol.com | Captisol.com 2033 Becker Drive | Suite 310 | Lawrence, KS 66047